Search bioRxivSearch

Biology subjects

Shapira, G.

Publications and source records attributed to Shapira, G..

3 recordsLinked to original sources

Mutants libraries reveal negative design shielding proteins from mis-assembly and re-localization in cells

Understanding the molecular consequences of mutations in proteins is essential to map genotypes to phenotypes and interpret the increasing wealth of genomic data. While mutations are known to disrupt protein structure and function, their potential to create new structures and localization phenotypes has not yet been mapped to a sequence space. To map this relationship, we employed two homo-oligomeric protein complexes where the internal symmetry exacerbates the impact of mutations. We mutagenized three surface residues of each complex and monitored the mutations effect on localization and assembly phenotypes in yeast cells. While surface mutations are classically viewed as benign, our analysis of several hundred mutants revealed they often trigger three main phenotypes in these proteins: nuclear localization, the formation of puncta, and fibers. Strikingly, more than 50% of random mutants induced one of these phenotypes in both complexes. Analyzing the mutants sequences showed that surface stickiness and net charge are two key physicochemical properties associated with these changes. In one complex, more than 60% of mutants self-assembled into fibers. Such a high frequency is explained by negative design: charged residues shield the complex from misassembly, and the sole removal of the charges induces its assembly. A subsequent analysis of several other complexes targeted with alanine mutations suggested that negative design against mis-assembly and mislocalization is common. These results highlight that minimal perturbations in protein surfaces physicochemical properties can frequently drive assembly and localization changes in a cellular context.

biophysics

Reconstruction Algorithms for DNA-Storage Systems

In the trace reconstruction problem a length-n string x yields a collection of noisy copies, called traces, y1, ..., yt where each yi is independently obtained from x by passing through a deletion channel, which deletes every symbol with some fixed probability. The main goal under this paradigm is to determine the required minimum number of i.i.d traces in order to reconstruct x with high probability. The trace reconstruction problem can be extended to the model where each trace is a result of x passing through a deletion-insertion-substitution channel, which introduces also insertions and substitutions. Motivated by the storage channel of DNA, this work is focused on another variation of the trace reconstruction problem, which is referred by the DNA reconstruction problem. A DNA reconstruction algorithm is a mapping [Formula] which receives t traces y1, ..., yt as an input and produces [Formula], an estimation of x. The goal in the DNA reconstruction problem is to minimize the edit distance [Formula] between the original string and the algorithms estimation. For the deletion channel case, the problem is referred by the deletion DNA reconstruction problem and the goal is to minimize the Levenshtein distance [Formula]. In this work, we present several new algorithms for these reconstruction problems. Our algorithms look globally on the entire sequence of the traces and use dynamic programming algorithms, which are used for the shortest common supersequence and the longest common subsequence problems, in order to decode the original sequence. Our algorithms do not require any limitations on the input and the number of traces, and more than that, they perform well even for error probabilities as high as 0.27. The algorithms have been tested on simulated data as well as on data from previous DNA experiments and are shown to outperform all previous algorithms.

bioinformatics

Transient cell-in-cell formation underlies tumor resistance to immunotherapy

Despite the remarkable success of immunotherapy in cancer, most patients will develop resistant tumors. While the main conceptual paradigm suggests that relapsed clones emerge through a process of clonal selection and immunoediting, currently little evidence directly demonstrates this process in epithelial cancers. To study this process, we established several mouse models in which tumors drastically regress following immunotherapy, yet resistant tumors relapse within a few weeks of treatment cessation. Whole exome analyses indicated that relapsed tumors share hundreds of neo-antigens with the primary tumors and are comparably killed by reactive T cells. Examination of tumor cells that survive immunotherapies revealed that they structure a transient cell-in-cell formation, which is impenetrable to immune-derived cytotoxic compounds and to chemotherapies. This formation is mediated predominantly by a cell-membrane protein on activated T cells, which subsequently induces epidermal growth factor receptors and STAT3 phosphorylation in tumors cells. In contrast to previous reports on cell-in-cell formations, here both cells remain alive and can disseminate into single tumor cells once T cells are no longer present. Overall, this work highlights a powerful resistance mechanism which enable tumor cells to survive immune pressure and provides a new theoretical framework for combining chemotherapies and immunotherapies.

immunology